RDMD, a San Francisco-based company, has a plan to address that impasse by serving as a conduit between the patient and the drug developer. The platform courts patients with rare diseases by helping them access medical records and participate in research, while for drug developers, the company structures the compiled data in an effort to build research programs and develop an evidence base palatable for regulatory authorities.
2 Likes
Admins, can we reach out to these guys for PFS, SSRI & PAS?
1 Like
Already have done in the case of Zuckerberg Chan. Will look into the other.
1 Like
Just took a look at Chan.
Looks too broad compared to RDMD.
The latter zeros all efforts on to us for our specific needs
1 Like